Paris company using generative AI and lab robotics to design and synthesise new drug molecules faster.
This profile is maintained by the Sesamers data desk. Claim it to edit details, post jobs and answer interviews.
€15,500,000
Total raised
-
Valuation
11-50
Employees
2016
Founded
Latest round
Series A - March 9, 2023
Series A - €15,500,000
March 9, 2023
Omnes Capital - Verified by the Sesamers desk M Ventures and Debiopharm Innovation Fund (co-leads)
M Ventures, Debiopharm Innovation Fund, Omnes Capital
✓ verified by our desk
Open roles
Iktos is not hiring through Sesamers right now.
Work here? Claim the profile and post roles.
Claim your profile